The Valley Desk

NCT06824987 · Interventional trial

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

Overall registry status Active not recruiting

Phase 2

Conditions APOL1-Mediated Kidney Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov